Fresenius | FRE - Umsatzkosten

Aktienkurs
41.40
Täglich Wechseln
0.61 1.50%
Monatlich
-7.15%
Jährlich
-0.96%
Q2 Prognose
39.19




Umsatzkosten Veränderung Datum
Akzo Nobel EUR 1.41B 28M 2026-03
Alcon AG USD 1.2B 46M 2025-12
AstraZeneca USD -204M 3.48B 2026-03
BASF EUR 10.93B 241M 2025-12
Bayer EUR 4.5B 194M 2025-12
Beiersdorf EUR 2.06B 50M 2025-12
DaVita Healthcare Partners USD 2.6B 263.46M 2025-12
Demant DKK 2.89B 188M 2025-12
E.ON EUR 16.3B 4.97B 2025-12
Essilor EUR 6.06B 741M 2025-12
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.68B 38.37M 2025-12
Getinge SEK 6.02B 1.7B 2024-12
Givaudan CHF 2.07B 105M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
GN Store Nord DKK 2.24B 338M 2025-12
GRIFOLS EUR 1.29B 163.12M 2025-12
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.29B 183M 2025-12
Novartis USD 3.54B 3M 2025-12
Philips EUR 2.81B 417M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
RWE EUR 2.81B 326M 2025-12
Sanofi EUR 3.67B 621M 2026-03
Smith & Nephew USD 870M 17M 2025-12